Hepatitis C treatment: Trial by design

Hepatitis C treatment: Trial by design

Bibliografske podrobnosti
Glavni avtor:	Bzeizi Khalid
Format:	Article
Jezik:	English
Izdano:	Wolters Kluwer Medknow Publications 2008-01-01
Serija:	The Saudi Journal of Gastroenterology
Online dostop:	http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2008;volume=14;issue=2;spage=51;epage=52;aulast=Bzeizi

Podobne knjige/članki

Coincidence of acute <i>Brucella</i> hepatitis and dengue fever or serologic cross-reactivity?
od: Bzeizi Khalid, et al.
Izdano: (2010-01-01)

Albumin use in cirrhotic patients: The case against
od: Syed Muhammad, et al.
Izdano: (2007-01-01)

Randomized controlled trial using education material to improve hepatitis C treatment adherence among hepatitis C patients in Tripoli Medical Center
od: Adam, Samia Ibrahim Mohamed, et al.
Izdano: (2017)

Hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial
od: Mazhar Haque, et al.
Izdano: (2009-01-01)

Rationale and design of a randomized controlled trial of directly observed hepatitis C treatment delivered in methadone clinics
od: Litwin Alain H, et al.
Izdano: (2011-11-01)

Epidemiology and Treatment of Hepatitis C Genotypes 5 and 6
od: Khalid Al Naamani, et al.
Izdano: (2013-01-01)

The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Linkage-to-Care Trial: rationale and design of an emergency department-based randomized clinical trial of linkage-to-care strategies for hepatitis C
od: Sarah E. Rowan, et al.
Izdano: (2023-01-01)

The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Screening Trial: rationale and design of a multi-center pragmatic randomized clinical trial of hepatitis C screening in emergency departments
od: Jason S. Haukoos, et al.
Izdano: (2022-04-01)

The Evolution of Hepatitis C Treatment
od: Masoomeh Sofian
Izdano: (2018-10-01)

Design of a multicenter randomized clinical trial for treatment of Alcohol-Associated Hepatitis
od: Wanzhu Tu, et al.
Izdano: (2023-04-01)

Treatment options to support the elimination of Hepatitis C: an open label, factorial randomised controlled trial
od: Cooke, G, et al.
Izdano: (2025)

Planning a programme of pre-authorisation clinical trials of medicines for the treatment of chronic hepatitis C
od: A. I. Gubenko, et al.
Izdano: (2019-03-01)

Development of novel treatments for hepatitis C.
od: Webster, D, et al.
Izdano: (2009)

Emerging therapies for the treatment of hepatitis C
od: Christian M Lange, et al.
Izdano: (2013-09-01)

Treatment of hepatitis C in patients with thalassemia
od: Emanuele Angelucci, et al.
Izdano: (2008-08-01)

Innovations in Hepatitis C Screening and Treatment
od: Arpan A. Patel, et al.
Izdano: (2021-03-01)

Treatment guidelines for Hepatitis C in Spain
od: M. Crespo-Casal

Takayasu's arteritis and liver transplantation: Association and implications
od: Fahdah Alokaily, et al.
Izdano: (2015-01-01)

Treatment of chronic hepatitis C in treatment-naïve patients
od: Marcelo Simão Ferreira

2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
Izdano: (2018-09-01)

Eliminating hepatitis C in a rural Appalachian county: protocol for the Kentucky Viral Hepatitis Treatment Study (KeY Treat), a phase IV, single-arm, open-label trial of sofosbuvir/velpatasvir for the treatment of hepatitis C
od: Peter Vickerman, et al.
Izdano: (2021-07-01)

Predictors of non-adherence of hepatitis C patients to treatment: a systematic review
od: Ibrahim Adam, Samia, et al.
Izdano: (2017)

Safety and efficacy of limited laboratory monitoring for hepatitis C treatment: a blinded clinical trial in Rwanda
od: Grant, P, et al.
Izdano: (2020)

Safety and Efficacy of Limited Laboratory Monitoring for Hepatitis C Treatment: A Blinded Clinical Trial in Rwanda
od: Philip Grant, et al.
Izdano: (2020-04-01)

Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)
od: Marina V. Mayevskaya, et al.
Izdano: (2018-08-01)

Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B
od: Faisal M. Sanai, et al.
Izdano: (2017-08-01)

Industry’s role in HIV, hepatitis B, and hepatitis C exclusion in AML and MDS clinical trials
od: Tahsin Anwar, et al.
Izdano: (2023-12-01)

New drugs in the treatment of chronic hepatitis C
od: R. Jimenez Galan, et al.
Izdano: (2014-04-01)

Treatment approach in chronic hepatitis C infection
od: Aslıhan Ulu, et al.
Izdano: (2016-06-01)

Treatment approach in chronic hepatitis C infection
od: Suheyla Komur, et al.
Izdano: (2016-06-01)

Hyperpigmentation of Tongue Associated with Hepatitis C Treatment
od: Aşkın Erdoğan, et al.
Izdano: (2013-06-01)

Viral hepatitis B and C. Cure or treatment?
od: Dimitrios A. Kountouras
Izdano: (2014-12-01)

Hepatitis C Treatment: A Review and Update
od: Jelena Jakab, et al.
Izdano: (2017-04-01)

Hepatitis C treatment: where are we now?
od: Burstow NJ, et al.
Izdano: (2017-02-01)

Hepatitis C Treatment: current and future perspectives
od: Akram Madiha, et al.
Izdano: (2010-11-01)

Strategies for hepatitis C virus treatment failure
od: Shang-Chin Huang, et al.
Izdano: (2022-05-01)

Prospects for current hepatitis C treatment failures
od: Vicente Soriano
Izdano: (2016-05-01)

Predictors of response to chronic hepatitis C treatment
od: Henrique Sergio Moraes Coelho, et al.
Izdano: (2010-01-01)

Hepatitis C diagnostics and treatment guidelines in adults
od: V. T. Ivashkin, et al.
Izdano: (2013-05-01)

Modern modes of chronic hepatitis C treatment
od: V. T. Ivashkin, et al.
Izdano: (2012-02-01)